KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Idexx Laboratories (IDXX) Enterprise Value (2016 - 2025)

Idexx Laboratories has reported Enterprise Value over the past 17 years, most recently at -$180.1 million for Q4 2025.

  • Quarterly results put Enterprise Value at -$180.1 million for Q4 2025, up 37.53% from a year ago — trailing twelve months through Dec 2025 was -$180.1 million (up 37.53% YoY), and the annual figure for FY2025 was -$180.1 million, up 37.53%.
  • Enterprise Value for Q4 2025 was -$180.1 million at Idexx Laboratories, up from -$208.2 million in the prior quarter.
  • Over the last five years, Enterprise Value for IDXX hit a ceiling of -$99.2 million in Q3 2022 and a floor of -$453.9 million in Q4 2023.
  • Median Enterprise Value over the past 5 years was -$192.3 million (2022), compared with a mean of -$227.2 million.
  • Peak annual rise in Enterprise Value hit 62.31% in 2021, while the deepest fall reached 332.55% in 2021.
  • Idexx Laboratories' Enterprise Value stood at -$144.5 million in 2021, then increased by 22.09% to -$112.5 million in 2022, then tumbled by 303.33% to -$453.9 million in 2023, then soared by 36.5% to -$288.3 million in 2024, then soared by 37.53% to -$180.1 million in 2025.
  • The last three reported values for Enterprise Value were -$180.1 million (Q4 2025), -$208.2 million (Q3 2025), and -$164.6 million (Q2 2025) per Business Quant data.